Kathy Giusti, a multiple myeloma patient, is the Founder of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). She is the Henry & Allison McCance Family Senior Fellow at Harvard Business School, where she serves as Faculty Co-Chair of HBS Kraft Precision Medicine Accelerator, a $20M program endowed by Robert Kraft and the Kraft Family Foundation. She currently serves on the MMRF Board of Directors. Giusti has more than two decades of experience in the pharmaceutical industry, previously holding senior positions at G.D. Searle and Merck.
Since founding the MMRF in 1998, Giusti has become a widely respected leader in establishing innovative, collaborative research models in the areas of tissue banking, genomics, and clinical trials. These models are dramatically accelerating the pace at which lifesaving treatments are brought to patients and are building an end-to-end solution in precision medicine. Today, Giusti is recognized as a pioneer of precision medicine, a champion of open-access data sharing, and a strong advocate for patient engagement.
In 2016, Giusti was named Faculty Co-Chair of the Harvard Business School (HBS) Kraft Precision Medicine Accelerator. Under Giusti’s leadership, the HBS Kraft Precision Medicine Accelerator convenes best-in-class leaders from science, business and technology to identify and solve challenges slowing the advancement of precision medicine. The HBS Kraft PM Accelerator disseminates best practices and models to overcome these challenges, and, ultimately, enables faster adoption of high-impact innovations.
Giusti’s has earned several prestigious awards and recognitions, including being named 1 of 3 Top Business Leaders Disrupting Medicine by Fortune Magazine and #19 on Fortune’s World’s 50 Greatest Leaders list. Giusti was also named one of the world’s 100 Most Influential People by TIME magazine. She has received the Open Science Champion of Change award by the White House and has been honored with the American Association for Cancer Research Centennial Medal for Distinguished Public Service and the Healthcare Businesswomen’s Association’s Woman of the Year Award.
Giusti served on President Obama’s 2015 Precision Medicine Initiative Working Group and continues to act as an active advisor to the Obama PMI (“All of Us”) and Vice President Biden’s Cancer Moonshot program. She currently is a member of the Harvard Business School (HBS) Health Advisory Board and has previously served on the President’s Council of Advisors on Science and Technology (PCAST), National Cancer Advisory Board (NCAB), and the National Cancer Policy Board (NCBP).
Giusti has been featured on the Today Show, NBC Nightly News, CBS Evening News, Fox News, CNN, and Bloomberg. Her efforts have also been profiled by Fortune, The Wall Street Journal, Harvard Business Review, The New York Times, Forbes, The New Yorker, WIRED, and Fast Company.
Giusti received her MBA in general management from Harvard Business School. She holds an honorary Doctorate from the University of Vermont.
Richard Hamermesh is a Senior Fellow at the Harvard Business School where he was formerly the MBA Class of 1961 Professor of Management Practice. Richard created and teaches the second-year MBA elective, Building Life Science Businesses. Previously, he was the Course Head for the required first year course, The Entrepreneurial Manager. In addition, Richard participates in several HBS Executive Education programs.
Richard was the founding Faculty Chair of the HBS Healthcare Initiative and has been instrumental in expanding the role of healthcare in MBA education and faculty research. Today, over 10% of students enrolled at Harvard Business School are pursuing careers in healthcare. Currently, Richard is the faculty co-chair of the Kraft Precision Medicine Accelerator.
From 1987 to 2001, Richard was a co-founder and a Managing Partner of The Center for Executive Development, an executive education and development consulting firm. Prior to this, from 1976 to 1987, he was a member of the faculty of the Harvard Business School.
Richard is also an active investor and entrepreneur, having participated as a principal, director, and investor in the founding and early stages of over 20 organizations. These have included start-ups, leveraged buy-outs, industry roll-ups, and non-profit foundations. He was the founding president of the Newton (MA) Schools Foundation and served on the editorial board of the Harvard Business Review. Richard has served on numerous Boards of Directors, and has chaired the Audit Committees of two public companies. He is currently on the Boards of two public and two private corporations. From 1991 to 1996, he was the founding Chairman of Synthes Spine, Inc.
Richard is the author or co-author of five books, including New Business Ventures and the Entrepreneur. His best-known book, Fad-Free Management, was published in 1996. He has published numerous articles and more than 100 case studies. His most recent article, "Realizing the Promise of Personalized Medicine," appeared in the Harvard Business Review (October 2007). Richard received his AB from the University of California, and his MBA and DBA from HBS.
Upon graduation from Williams College in 1986, Jonathan started his career at Bain & Co. After earning his MBA at Harvard Business School, he joined the Kraft Group in 1990. Since that time, he has worked to help drive the growth and diversification of the Kraft Group. In his role as President, Jonathan is responsible for overseeing the day-to-day activities of each of the Kraft Group’s operating businesses and outlining the plan for future growth and diversification.
Jonathan serves on the Board of Dean’s Advisors at Harvard Business School and is also on the board of trustees for several organizations, including Massachusetts General Hospital, where he is chair of the Finance Committee, Belmont Hill School and Dexter Southfield. He is a Trustee Emeritus of Williams College and chair of the Williams College Investments Committee. Additionally, he also chairs the Boston Children’s Hospital Stem Cell Advisory Board.
Robert Kraft is the Founder, Chairman and CEO of The Kraft Group, based in Foxborough, Mass. The Kraft Group is the holding company of the Kraft family's many businesses, including the New England Patriots, the New England Revolution, Gillette Stadium, Patriot Place, International Forest Products, Rand-Whitney Group, Rand-Whitney Containerboard and a portfolio of more than 100 private equity investments.
Kraft began his business career with the Rand-Whitney Group, Inc. of Worcester, Mass. In 1972, he founded International Forest Products (IFP), a trader of paper commodities that now does business in more than 90 countries. IFP has consistently ranked in the top 20 overall exporters in North America according to the annual rankings published by The Journal of Commerce.
Kraft is widely recognized as one of the most successful owners in professional sports. As Chairman and CEO of the New England Patriots, combined with the New England Revolution, Kraft changed the culture of professional sports in New England by delivering 12 conference titles and four league championships in the past 18 years. Since 1994, the Patriots have won more games, including playoff games (24), division titles (14), conference titles (7) and Super Bowls (4) than any other team in the NFL. Kraft also has the only privately financed world-class sports and entertainment complex with the construction of Gillette Stadium with no personal seat licenses and Patriot Place.
A native of Brookline, Mass., Kraft attended public schools before attending Columbia on an academic scholarship. Upon graduation, he received a fellowship to Harvard Business School. He is a governing trustee on the board of trustees for the Dana-Farber Cancer Institute, where he established the Robert K. Kraft Blood Donor Center. He is a trustee emeritus at Columbia and a trustee at Boston College. He has received many honorary degrees from several colleges and universities and was awarded the NCAA’s highest honor when he received the Theodore Roosevelt Award, presented annually to a “distinguished citizen of national reputation and outstanding accomplishments.” He has received the Harvard Business School Alumni Achievement Award as well as the prestigious honor of being inducted into the 231st class of American Academy of Arts and Sciences. In 2012, he became the first NFL owner in the 43-year history of the honor to receive the George Halas Award, which is presented annually to the NFL player, coach or staff member who overcomes the most adversity to succeed. In 2012, he was inducted into Columbia’s Athletic Hall of Fame.
Over the past five decades, the Kraft family has been one of New England’s most philanthropic families, donating hundreds of millions of dollars in support of local charities, civic affairs and health care, including a $25 million pledge to Partners HealthCare to launch the Kraft Center for Community Health and a $20 million pledge to Harvard Business School to establish an endowment for the advancement of precision medicine.
Eric Lander is president and founding director of the Broad Institute of MIT and Harvard. A geneticist, molecular biologist, and mathematician, he has played a pioneering role in the reading, understanding, and biomedical application of the human genome. He was a principal leader of the Human Genome Project. Lander is professor of biology at MIT and professor of systems biology at Harvard Medical School. In 2008, he was appointed by President Obama as co-chair of the President’s Council of Advisors on Science and Technology. Lander’s numerous honors include the Gairdner Foundation Award, Dan David Prize, and Breakthrough Prize in Life Sciences.
Nitin Nohria became the tenth Dean of Harvard Business School on July 1, 2010. He is also the George F. Baker Professor of Administration. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and head of the organizational behavior unit. He joined the HBS faculty in July 1988.
Building on input from faculty, students, staff, and alumni, Nohria has identified five priorities for HBS: (1) innovation in the School’s educational programs, beginning with the MBA Program; (2) intellectual ambition that advances ideas with impact in practice; (3) continued internationalization, through building a global intellectual footprint; (4) creation of a culture of inclusion, where every member of the community can do his or her best work in support of the School’s mission; and (5) fostering a culture of integration within HBS and across Harvard University that acts as a catalyst for entrepreneurship.
Dean Nohria has taught courses across the School’s MBA, doctoral, and Executive Education programs. His intellectual interests center on human motivation, leadership, corporate transformation and accountability, and sustainable economic and human performance. He is a coauthor or coeditor of 16 books.
Dean Nohria received a bachelor’s in chemical engineering from the Indian Institute of Technology, Bombay, and a doctorate in management
→ Media Center